Data Insights
By Company Name
No Filter Selected
By Disease Name
No Filter Selected
By Drug Name
No Filter Selected
By Themes
No Filter Selected
Showing 1 results out of 1
Data Insights
EXE-346 by ExeGi Pharma for Pouchitis: Likelihood of Approval
EXE-346 is under clinical development by ExeGi Pharma and currently in Phase II for Pouchitis. According to GlobalData, Phase II...